Drug Price Transparency
Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|---|---|---|---|---|
| Complera | 01/01/2024 | Emtricita/Rilpivirine/Tenof Df | increased | 972.23 | 100 |
| Complera | 01/01/2024 | Emtricita/Rilpivirine/Tenof Df | increased | 972.23 | 100 |
| Condylox | 01/01/2024 | Podofilox | increased | 972.23 | 100 |
| Condylox | 01/01/2024 | Podofilox | increased | 972.23 | 100 |
| Copaxone | 01/01/2024 | Glatiramer Acetate | increased | 972.23 | 100 |
| Copaxone | 01/01/2024 | Glatiramer Acetate | increased | 972.23 | 100 |
| Copiktra | 01/01/2024 | Duvelisib | increased | 972.23 | 100 |
| Copiktra | 01/01/2024 | Duvelisib | increased | 972.23 | 100 |
| Cordran | 01/01/2024 | Flurandrenolide | increased | 972.23 | 100 |
| Cordran | 01/01/2024 | Flurandrenolide | increased | 972.23 | 100 |
| Cortrophin | 01/01/2024 | Corticotropin | increased | 972.23 | 100 |
| Cortrophin | 01/01/2024 | Corticotropin | increased | 972.23 | 100 |
| Cosela | 01/01/2024 | Trilaciclib Dihydrochloride | increased | 972.23 | 100 |
| Cosela | 01/01/2024 | Trilaciclib Dihydrochloride | increased | 972.23 | 100 |
| Cosentyx (2 Syringes) | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx (2 Syringes) | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Sensoready (2 Pens) | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Sensoready (2 Pens) | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Sensoready Pen | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Sensoready Pen | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Syringe | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Syringe | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Unoready Pen | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx Unoready Pen | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cosentyx | 01/01/2024 | Secukinumab | increased | 972.23 | 100 |
| Cotellic | 01/01/2024 | Cobimetinib Fumarate | increased | 972.23 | 100 |
| Cotellic | 01/01/2024 | Cobimetinib Fumarate | increased | 972.23 | 100 |
| Cresemba* | 01/01/2024 | Isavuconazonium Sulfate | increased | 972.23 | 100 |
| Cresemba* | 01/01/2024 | Isavuconazonium Sulfate | increased | 972.23 | 100 |
| Crysvita | 01/01/2024 | Burosumab-Twza | increased | 972.23 | 100 |
| Crysvita | 01/01/2024 | Burosumab-Twza | increased | 972.23 | 100 |
| Crysvita | 01/01/2024 | Burosumab-Twza | increased | 972.23 | 100 |
| Cuprimine | 01/01/2024 | Penicillamine | increased | 972.23 | 100 |
| Cuprimine | 01/01/2024 | Penicillamine | increased | 972.23 | 100 |
| Cuvrior | 01/01/2024 | Trientine Tetrahydrochloride | increased | 972.23 | 100 |
| Cuvrior | 01/01/2024 | Trientine Tetrahydrochloride | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyclophosphamide* | 01/01/2024 | Cyclophosphamide | increased | 972.23 | 100 |
| Cyltezo(Cf) Pen Crohn'S-Uc-Hs | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Cyltezo(Cf) Pen Crohn'S-Uc-Hs | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |
| Cyltezo(Cf) Pen Psoriasis-Uv | 01/01/2024 | Adalimumab-Adbm | increased | 972.23 | 100 |